TransEnterix Acquires Surgical Robotics Division of Sofar
Summary
TransEnterix acquired Sofar’s surgical robotics division for $99.8 million in cash and stock. The deal adds Sofar’s Telelap ALF-X minimally invasive robotic surgery system to TransEnterix’s portfolio. The company expects to commercialize ALF-X quickly in markets where it already carries a CE mark. Management says the acquisition expands the addressable market and should accelerate revenue growth. Sofar’s CEO also joined TransEnterix’s board and became a significant shareholder.
AskAI Classifications
Sectors
HealthTech
General Healthcare software
Medical Devices and Health IoT
Functions
No functions detected
Linked Companies
Asensus Surgical
$10M to $25M